Covered recipient · General Payments record
LINDA J SCHUMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,430.25
- Reported across 372 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $568.62 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $210.72 | 17 |
| ABBVIE INC. | $190.02 | 10 |
| PFIZER INC. | $76.42 | 5 |
| Otsuka America Pharmaceutical, Inc. | $21.79 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.81 | 1 |
| Kyowa Kirin, Inc. | $20.23 | 1 |
| Lilly USA, LLC | $14.78 | 1 |
| GlaxoSmithKline, LLC. | $13.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.48 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043518 | CMS |
| ABBVIE INC. | $26.97 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043520 | CMS |
| ABBVIE INC. | $25.54 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043522 | CMS |
| ABBVIE INC. | $6.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043524 | CMS |
| ABBVIE INC. | $19.69 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043526 | CMS |
| ABBVIE INC. | $18.25 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043528 | CMS |
| ABBVIE INC. | $30.92 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043530 | CMS |
| ABBVIE INC. | $11.45 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043532 | CMS |
| ABBVIE INC. | $20.87 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043534 | CMS |
| ABBVIE INC. | $7.85 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043536 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.81 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117999493 | CMS |
| GlaxoSmithKline, LLC. | $13.85 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116237813 | CMS |
| Kyowa Kirin, Inc. | $20.23 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127035784 | CMS |
| Lilly USA, LLC | $14.78 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135135060 | CMS |
| Novo Nordisk Inc | $17.48 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097283925 | CMS |
| Novo Nordisk Inc | $8.79 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097260378 | CMS |
| Novo Nordisk Inc | $10.07 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097399141 | CMS |
| Novo Nordisk Inc | $8.69 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097435512 | CMS |
| Novo Nordisk Inc | $1.25 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097477614 | CMS |
| Novo Nordisk Inc | $2.63 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573016 | CMS |
| Novo Nordisk Inc | $9.79 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097835504 | CMS |
| Novo Nordisk Inc | $11.31 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096662092 | CMS |
| Novo Nordisk Inc | $13.03 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097085428 | CMS |
| Novo Nordisk Inc | $14.91 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096945672 | CMS |
| Novo Nordisk Inc | $18.61 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096854283 | CMS |
| Novo Nordisk Inc | $15.01 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096593456 | CMS |
| Novo Nordisk Inc | $17.07 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097395706 | CMS |
| Novo Nordisk Inc | $9.90 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096891913 | CMS |
| Novo Nordisk Inc | $16.63 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097186156 | CMS |
| Novo Nordisk Inc | $21.27 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097177324 | CMS |
| Novo Nordisk Inc | $14.28 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097677029 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.79 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118977896 | CMS |
| PFIZER INC. | $15.51 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131043899 | CMS |
| PFIZER INC. | $13.14 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131260658 | CMS |
| PFIZER INC. | $13.14 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131438235 | CMS |
| PFIZER INC. | $21.03 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132011094 | CMS |
| PFIZER INC. | $13.60 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131007614 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.